Subject Index vol. 19,1996
R. Parwaresch, B. Bültmann, T. Wiegel, W. H. Hoffmann, Wolfgang E. Berdel(University Hospital Münster), D. Comely, E. Dühmke, K. Mross, Karen L. Herbst(The Roxbury Institute), C. Degner, M. Lehnert(Merck & Co., Inc., Rahway, NJ, USA (United States)), Ursula Vogel, Katharina Holstein, T.M.M. de Reijke, M. Schiebe, I.-M. von Broen, A. Korfel, Michélle Busch, D.K. Hossfeld, N. Runkel, K. H. Kurth, H.J. Weh, T. Franke, D. H. J. Schamhart, Elizabeth C. de Boer, T.A. Walter, P. Rudolph, Y. Bankmann, M. Bamberg(Universitätsklinikum Tübingen), Margret Rave‐Fränk
Cited by 0
Related Papers
Phase I Study of Pembrolizumab (MK-3475; Anti–PD-1 Monoclonal Antibody) in Patients with Advanced Solid Tumors
|Clinical Cancer Research|2015|799
Osteosarcoma Relapse After Combined Modality Therapy: An Analysis of Unselected Patients in the Cooperative Osteosarcoma Study Group (COSS)
|Journal of Clinical Oncology|2005|654